Literature DB >> 15955037

MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura.

P S Sándor1, U Dydak, J Schoenen, S S Kollias, K Hess, P Boesiger, R M Agosti.   

Abstract

Migraine pathophysiology possibly involves deficient mitochondrial energy reserve and diminished cortical habituation. Using functional magnetic resonance spectroscopic imaging (fMRSI), we studied cortical lactate changes during prolonged visual stimulation to search for different pathophysiological mechanisms in clinically distinct subgroups of migraine with aura. Eleven healthy volunteers (HV) and 10 migraine patients were investigated interictally: five with visual aura (MA) and five with visual symptoms and at least one of the following: paraesthesia, paresis or dysphasia (MAplus). Using MRSI (Philips, 1.5 T) (1)H-spectra were repeatedly obtained from a 25 mm-thick slice covering visual and non-visual cortex, with the first and fifth measurements in darkness and the second to fourth with 8-Hz checkerboard stimulation. In MAplus lactate increased only during stimulation, only in visual cortex; in MA resting lactate was high in visual cortex, without further increase during stimulation. This is compatible with an abnormal metabolic strain during stimulation in MAplus, possibly due to dishabituation, and a predominant mitochondrial dysfunction in MA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955037     DOI: 10.1111/j.1468-2982.2005.00900.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  21 in total

1.  (1)H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique.

Authors:  Harmen Reyngoudt; Yves De Deene; Benedicte Descamps; Koen Paemeleire; Eric Achten
Journal:  MAGMA       Date:  2010-08-13       Impact factor: 2.310

2.  Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field.

Authors:  Nastaren Abad; Jens T Rosenberg; Tangi Roussel; Dillon C Grice; Michael G Harrington; Samuel C Grant
Journal:  Magn Reson Med       Date:  2017-09-17       Impact factor: 4.668

Review 3.  Kynurenines and headache.

Authors:  Arpád Párdutz; Annamária Fejes; Zsuzsanna Bohár; Lilla Tar; József Toldi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-06-04       Impact factor: 3.575

4.  Neurochemical metabolite alterations of the occipital lobe in migraine without aura by proton magnetic resonance spectroscopy.

Authors:  Alireza Dehghan; Erfan Saatchian; Mohammadreza Sobhani; Alireza Montazerabadi
Journal:  Neuroradiol J       Date:  2020-06-23

5.  Brain lactate responses during visual stimulation in fasting and hyperglycemic subjects: a proton magnetic resonance spectroscopy study at 1.5 Tesla.

Authors:  Richard J Maddock; Michael H Buonocore; Shawn P Lavoie; Linda E Copeland; Shawn J Kile; Anne L Richards; John M Ryan
Journal:  Psychiatry Res       Date:  2006-10-03       Impact factor: 3.222

Review 6.  Migraine changes the brain: neuroimaging makes its mark.

Authors:  Till Sprenger; David Borsook
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

7.  Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS study.

Authors:  Harmen Reyngoudt; Koen Paemeleire; Anneloor Dierickx; Benedicte Descamps; Pieter Vandemaele; Yves De Deene; Eric Achten
Journal:  J Headache Pain       Date:  2011-02-08       Impact factor: 7.277

Review 8.  Advanced neuroimaging of migraine.

Authors:  Todd J Schwedt; David W Dodick
Journal:  Lancet Neurol       Date:  2009-06       Impact factor: 44.182

9.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

Review 10.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.